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Metastasis accounts for a majority of cancer death. One key feature during metastasis is epithelial-mesenchymal 
transition (EMT), which is regulated by transcription factors such as Snail and Twist. In non-malignant cells, 
Snail has a short half-life and is degraded via ubiquitination, but its stability is increased in cancer cell. 
However, the mechanism by which Snail escapes ubiquitination and degradation remains unknown. Recently, 
we found that Dub3 is a deubiquinase of Snail. Most importantly, we determined that Dub3 responded to 
extracellular signals such as IL-6, and that the resultant signaling prevented Snail degradation, and promoted 
cancer growth, invasion, and migration. In this highlight, we present a concise picture of how the transcription 
factor Snail is regulated by ubiquitination in cancer cells, the role of Dub3 in this process, and its potential use as 
a treatment target. 
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The ubiquitination of Snail  
Metastasis accounts for 90% of cancer deaths [1]. In order 
to establish new growth at a distant location, cancer cells 
undergo invasion, intravasation, extravasation, and metastatic 
colonization [2-4]. During this process, EMT is necessary for 
cancer cells to lose their original intercellular adhesion and 
initially adopt an increased motility [5, 6]. Similar to the 
establishment of gestation layers by embryological cells, 
cancer cells undergoing EMT re-overexpress transcription 
factors such as Slug, Twist, and Snail, which repress proteins 
such as cadherin, claudin, integrin, cytokine, as well as 
others [5, 7]. Among these molecular triggers, Snail, a zinc 
finger protein family member, has been widely 
acknowledged for its role in EMT [5, 8-10]. Clinically, Snail 
expression is associated with resistance to chemotherapy, 
decreased survival, high recurrence rates and a poor 
prognosis [11-13]. In accordance with its profound role in 
development, Snail has a short half-life and is tightly 
regulated by extracellular signaling, induced phosphorylation 
and degradation through ubiquitination [14].  
The ubiquitination proteasome pathway is one approach 
utilized by cells to degrade targeted protein in eukaryotic cell 
[5]. During this process, ubiquitin, a 76 aminoacid peptide, 
initially forms a thio-ester bond with the ubiquitin activating 
enzyme (E1) and then is transferred to a ubiquitin 
conjugating enzyme (E2). Subsequently, a ubiquitin ligating 
RESEARCH HIGHLIGHT 
Cancer Cell & Microenvironment 2017; 4: e1567. doi: 10.14800/ccm.1567; © 2017 by Qian Yu, et al. 
http://www.smartscitech.com/index.php/ccm 
 
Page 2 of 5 
 
enzyme (E3) catalyzes the formation of a covalent bond 
between ubiquitin and a lysine residue on the target protein, 
which then becomes susceptible to proteasomal degradation 
[15]. Snail’s ubiquitination and degradation are controlled by 
several F-box ligases, including β-TRCP1/Fbxw1, Fbxl14, 
Fbxl5, Fbxo11, and Fbxo45 [16-22] (Figure 1). 
β-TRCP1/Fbxw1 is one of the best-characterized Snail E3 
ligase. To initiate the even, phosphorylation of Snail by 
GSK3β on residues S104 and S107 promotes Snail 
localization to the cytoplasm; additional phosphorylation 
events by GSK3β on the S96 and S100 residues generate the 
β-TRCP1 phosphodegron [17]. Fbxl14, a cytoplasmic F-box 
protein, shares the same lysine residues as β-TRCP1 in the 
Snail N-terminal domain: K98, K137 and K146 and through 
these associations ligates ubiquitin to Snail [21]. Through 
global shRNA screening of F-box proteins, Fbxl5 was 
identified as targeting Snail. Fbxl5 is localized 
predominantly in the nucleus. Interestingly, Fbxl5 interacts 
with the Snail C-terminus, the region involved in binding to 
the E-box sequence while it polyubiquitinates Snail on its 
N-terminal residues K85 and K146 as well as on its 
C-terminal residue K234 [18]. In addition, Fbxl5-induced 
Snail down-regulation is impaired by post-translational 
modifications that prevent nuclear export, such as Lats2 
phosphorylation [23]. Fbxo11 is another ubiquitin ligase that 
targets the SNAG domain of Snail [19,24]. Whether Snail 
degradation by Fbxo11 is dependent on S11 phosphorylation 
by the PKD1 is controversial and needs confirmation. The 
role of PKD1 –induced Snail phosphorylation is complex 
since PKD1 can either inhibit or enhance Snail 
transcriptional repression [25, 26]. Fbxo45 is an atypical F-box 
protein induced by estrogen [27]. Fbxo45 interacts with Snail 
through its F-box domain. Surprisingly, several of these E3 
ligases interacts as well with Slug, Zeb1 and Twist such as 
β-TRCP1, Fbxl14 and Fbxo45 while only Fbxl5 specifically 
interacts with Snail. Previously, we found that the expression 
of Snail can be stabilized by NF-κB at both transcriptional 
and post-translational levels, to downregulate the expression 
of E-cadherin and facilitate EMT [22, 28].   
Figure 1. The ubiquitination regulation of Snail. Snail is degraded by several E3 ligase including β-TRCP1, Fbxl14, 
Fbxl5, FBXO11 and Fbxo45. By contrast, Dub3 deubiquitinates Snail and prevents snail degradation through two axis: (1) 
the IL-6/Dub3/Snail axis: the extracellular IL-6 signal leads to increased Dub3 activity; (2) CDK4/6/Dub3/Snail axis: CDK4/6 
phosphorylates Dub3 at Ser41. Dub3 is responsible for EMT, cancer stem cell like traits, and invasiveness through Snail 
stabilization. 
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The deubiquitination of Snail  
One way to counteract this E3 ligase-mediated protein 
degradation is through deubiquitinase, which removes the 
ubiquitin moieties from target proteins and increases their 
stability [29]. Deubiquitinase enzymes (DUBs) are classified 
as UCH, USP, JAMM, OTU, and Ataxin-3/Josephin group. 
Growing evidence shows that DUBs are essential for the 
regulation of many cellular functions including transcription, 
DNA repair, apoptosis and cell cycle progression [30]. Dub3 
belongs to the USP group. Whereas Dub1 and Dub2 were 
identified in mice, Dub3 is their human counterpart [31]. This 
family of growth-regulatory deubiquitinating enzymes are 
immediate-early genes and are induced rapidly and 
transiently in response to cytokine stimuli [32]. Within last 
few years, the role of Dub3 has emerged as an important 
deubiquitinase in DNA repair, cell proliferation, 
transcriptional factor regulation and tumor metastasis. For 
example, by deubiquitinating histones H2A and H2B, Dub3 
impedes the recruitment of DNA repair factors such as 
53BP1 and BRCA1 and cripple the DNA damage response 
that occurs with genotoxic stress [33]. By decreasing the 
turnover rate of cdc25A phosphatase, Dub3 facilitates the 
G1/S transition and promote cancer cell proliferation [34,35]. 
Dub3 also regulate YAP/TAZ activity by controlling the 
stability of the E3 ligase ITCH, the LATS kinases and the 
AMOT family proteins [36]. Using siRNA library screen 
targeting the 99 known or putative DUBs, we identified 
Dub3 is a deubiquitinase of Snail. Dub3 stabilizes Snail via 
deubiqutination, downregulating E-cadherin expression and 
promoting EMT [37, 38]. The interaction of Snail with Dub3 is 
mediated at the N-terminal region of Snail, which holds the 
SNAG domain and is the most common binding site for E3 
[38]. Expression of Dub3 blocked Snail degradation mediated 
by the E3 ligases Fbxl14 and Fbxw1/β-TRCP1 [38]. 
Functionally, we found that the expression of Dub3 in breast 
cancer cell lines not only downregulates markers of luminal 
type of breast cancer, but also upregulates molecules 
associated with BLBC [38]. Knockdown of Dub3 inhibits 
migration, invasion and cancer stem cell (CSC)-like 
characteristics in cells by downregulating of Snail. By 
contrast, ectopic expression of Dub3 induces EMT through 
an upregulation of Snail. Most importantly, we found that 
depletion of Dub3 not only dampened spontaneous lung 
metastasis but also inhibited tumor recurrence. Clinically, 
Dub3 overexpression predicts a shortened relapse-free 
survival and higher probability of distant metastasis. These 
results strongly suggest that Dub3 can be a therapeutic target. 
IL-6, a major cytokine present in the tumor 
microenvironment, can induce EMT and promote metastasis 
through the STAT3 signaling pathway in breast cancer, head 
and neck cancer and pancreatic cancer [39]. Increased IL-6 
level predicts tumor recurrence, a poor response to 
chemotherapy, poor survival, and tumor metastasis [40]. IL-6 
is also identified as a major cytokine secreted by BLBC cells 
and is essential for the CSC-like characteristic of BLBC [41]. 
Interestingly, Dub3 activity and expression, at both the 
mRNA and protein levels, can be induced by IL-6 through 
the JAK/STAT3 signaling pathway [31, 38, 39]. Consistent with 
this, we also found that IL-6 rapidly induces Dub3 
expression, exerting a maximum effect at 2hr [38]. 
Dub3-knockdown not only reduced the endogenous level of 
Snail but also blocked IL-6-induced Snail stabilization and 
invasion. Thus, DUB3 could be a missing bridge between the 
extracellular signaling in the tumor environment and 
intracellular changes in genomic expression, and explains 
how tumor-promoting inflammation can facilitate cancer 
metastasis. These data delineate a key role by Dub3 in 
connecting extracellular inflammatory signals to invasion, 
CSC-like traits, and drug resistance.  
Considering the crucial role of Dub3 in triggering EMT 
and metastasis, we screened several Dub3 inhibitors and 
found that WP1130 could bind to the catalytic site of Dub3. 
In vitro, WP1130 inhibited cell migration, invasion, and 
mammosphere formation, whereas in vivo, tumor growth 
decreased significantly after treatment [38]. By blocking the 
interaction of Dub3 and Snail, WP1130 prevents the 
deubiquitination of Snail, thereby blocking cancer invasion, 
migration, and the establishment of CSC-like properties. 
Concurrently, palbociclib, a specific inhibitor of CDK4/6, 
was reported to decrease Snail stability in a Dub3-dependent 
manner [37]. CDK4/6 phosphorylates Dub3 at Ser41, a crucial 
site for Dub3 activity in the regulation of Snail’s stability [37]. 
By acting on the CDK4/6-Dub3-Snail axis, palbociclib 
reduced cancer cell migration and metastasis in vitro and in 
vivo. In both cases, the ultimate target was the Dub3-Snail 
interaction, suggesting critical role of Dub3-Snail axis in 
cancer progression and metastasis (Figure 1).   
Conclusion 
Snail has been well acknowledged for its importance in 
mediating EMT and tumor metastasis. Its stability is crucial 
for cancer progression and metastasis. We have identified 
Dub3 as the key regulator of Snail and the missing link 
between extracellular signaling from sources such as IL-6 in 
tumor environment, and the gene expression changes in cells 
that promote cancer. In addition, we exploited Dub3’s value 
as a therapeutic target. WP1130 reduces cancer migration 
and metastasis by inhibiting Dub3’s catalytic activity and 
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thereby restores the ubiquitination-mediated degradation of 
Snail. Based on Dub3’s dual role in regulating tumor growth 
and metastasis, future clinical and pharmaceutical 
investigations could be directed towards this specific 
interaction of Dub3-Snail. Last but not least, while our study 
indicated that Dub3 could counteract the function of 
β-TRCP1 and Fbxl14 in regulating the degradation of Snail, 
both β-TRCP1 and Fbxl14 could also influence the stability 
of Slug, ZEB1 and Twist. Future research could explore 
Dub3’s role in regulating these transcription factors [21,42,43]. 
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